Hawaii 2022 Regular Session

Hawaii House Bill HCR28

Introduced
3/3/22  
Refer
3/8/22  
Report Pass
3/30/22  
Refer
3/30/22  
Report Pass
4/7/22  
Engrossed
4/7/22  

Caption

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.

Impact

HCR28 reflects a growing recognition of the need for insurance coverage for fertility preservation, aligning Hawaii with trends in other states that have enacted similar mandates. The resolution emphasizes the necessity of comprehensive access to fertility preservation methods for cancer patients, which are increasingly recognized as standard care. It aims to assess existing gaps in coverage and the potential to alleviate financial burdens for individuals seeking these essential services, thereby potentially improving quality of life for survivors.

Summary

House Concurrent Resolution 28 (HCR28) requests the state auditor to evaluate the social and financial impacts of mandating health insurance coverage for fertility preservation procedures for individuals diagnosed with cancer who may face infertility due to their condition or its treatment. The resolution stems from the understanding that certain cancer treatments can severely impact reproductive organs, leading to challenges in procreation, with the procedures necessary for fertility preservation often being prohibitively expensive—sometimes exceeding $10,000.

Sentiment

The general sentiment around HCR28 appears supportive, particularly amongst advocacy groups focused on reproductive rights and cancer treatment. However, there is an underlying concern regarding the economic implications of such mandates on insurers and the healthcare system. The resolution seeks to clarify these impacts through the auditor's review and aims to foster informed discussion in the legislature about the necessity and feasibility of mandated coverage.

Contention

Notable points of contention surrounding HCR28 revolve around ethical questions related to cryopreserved materials and how they should be managed after a donor's death, including issues of ownership rights and decision-making authority. Additionally, discussions may emerge regarding the extent to which insurance should cover fertility preservation methods, whether they fall within 'essential health benefits', and possible implications for policyholders. The resolution, by involving an audit, aims to provide a comprehensive basis for these discussions and any potential legislative action.

Companion Bills

HI SCR241

Same As Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.

Similar Bills

HI SCR241

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.

HI SB2917

Relating To Family Planning.

HI SB758

Relating To Family Planning.

HI SB758

Relating To Family Planning.

HI SCR152

Requesting The Auditor To Assess The Social And Financial Effects Of Mandating Health Insurance Coverage For Oocyte Cryopreservation.

MA H1191

Improving access to infertility treatment

MA S689

Improving access to infertility treatment

HI HB139

Relating To Insurance.